Skip to content

Autonomic and Enteric Profiling

Autonomic and Enteric Profiling in Relation to Body Weight

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03178370
Enrollment
43
Registered
2017-06-06
Start date
2014-03-06
Completion date
2015-12-03
Last updated
2022-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroparesis

Keywords

Gastroparesis, Nausea and Vomiting, Abdominal Pain, Gastric Emptying, Electrophysiology, Hormones, Inflammation, Enteric Nervous System, Autonomic Nervous System

Brief summary

Autonomic, inflammatory, enteric, electrophysiologic and hormonal.

Detailed description

Patients were evaluated by two methods in each of five areas: inflammatory, autonomic, enteric, electrophysiologic, and hormonal. In part one, patients had similar GI Symptoms regardless of baseline gastric emptying or diabetic/non-diabetic status and all patients demonstrated abnormalities in each of the 5 areas studied. In part two, patients showed early and late effects of electrical stimulation with changes noted in multiple areas, categorized by improvement status.

Interventions

Temporary and permanent gastric electrical stimulation

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Louisville
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Willingness to participate in study and sign informed consent. 2. Age 18 or older. 3. Symptoms of gastroparesis for at least 6 months. 4. Refractory or intolerant to antiemetic drugs. 5. Refractory or intolerant to prokinetic drugs. 6. If Diabetic, documentation of medication for diabetes for at least 6 months. 7. No evidence of anatomic obstruction of GI tract. -

Exclusion criteria

1. Previous gastric surgery. 2. History or evidence of rumination syndrome, eating disorder of primary psychiatric disorder. 3. No know collagen vascular disease. 4. Inability or unwillingness to participate in the study. 5. Current active gastric stimulation or other gastrointestinal neurostimulation implant or device. 6. Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Gastrointestinal symptomsChange from baseline to 6 days to 6 monthsBy standardized symptom scoring

Secondary

MeasureTime frameDescription
AutonomicChange from baseline to 6 days to 6 monthsBy autonomic function
HormonesChange from baseline to 6 days to 6 monthsBy serum measures
InflammationChange from baseline to 6 days to 6 monthsBy serum measures
Gastric Emptying Testbaseline, 6 days, 6 monthsBy gastric emptying test
ElectrophysiologyChange from baseline to 6 days to 6 monthsBy Electrogastrogram(EGG)/ Electrogram (EG)
Quality of life by IDIOMSChange from baseline to 6 days to 6 monthsBy standardized scale
Gastric emptyingbaseline, 6 days, 6 monthsBy radionuclides

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026